Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein elicits antibodies targeting a membrane-proximal epitope
Ryan S. McCool(The University of Texas at Austin), Jason S. McLellan(The University of Texas at Austin), Alexandrine Derrien-Colemyn(National Institutes of Health), Tracy J. Ruckwardt(National Institutes of Health), Daniel Wrapp(Duke University), Maryam Musayev(National Institutes of Health), John R. Mascola(National Institute of Allergy and Infectious Diseases), Cory M. Acreman(The University of Texas at Austin), Sabrina M. Bush(National Institutes of Health), Barney S. Graham(National Institutes of Health)
Cited by 19
Related Papers
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
|Science|2020|9.8k
Site-specific glycan analysis of the SARS-CoV-2 spike
|Science|2020|1.7k
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
|Science|2020|1.4k
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
|Proceedings of the National Academy of Sciences|2017|1.2k